Josef D Schwarzmeier

Summary

Affiliation: University of Vienna
Country: Austria

Publications

  1. ncbi The role of soluble CD23 in distinguishing stable and progressive forms of B-chronic lymphocytic leukemia
    Josef D Schwarzmeier
    Department of Hematology, Clinic of Internal Medicine I, University of Vienna, Austria
    Leuk Lymphoma 43:549-54. 2002
  2. doi NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells
    Rainer Hubmann
    Clinic of Internal Medicine I, Department of Haematology and Haemostaseology, Medical University of Vienna, Waehringer Guertel 18 20, Vienna, Austria
    Br J Haematol 148:868-78. 2010
  3. pmc TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia
    Medhat Shehata
    Department of Hematology, Clinic of Internal Medicine I, Vienna, Austria
    J Clin Invest 113:676-85. 2004
  4. ncbi Effect of combined spa-exercise therapy on circulating TGF-beta1 levels in patients with ankylosing spondylitis
    Medhat Shehata
    Department of Hematology, Clinic of Internal Medicine I, University of Vienna, Austria
    Wien Klin Wochenschr 118:266-72. 2006
  5. ncbi Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia
    Rainer Hubmann
    Department of Hematology, Clinic of Internal Medicine I, University of Vienna, Vienna, Austria
    Blood 99:3742-7. 2002
  6. ncbi In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells
    Markus Duechler
    Ludwig Boltzmann Institute for Cytokine Research, Department of Hematology, Clinic of Internal Medicine I, University of Vienna, Austria
    Eur J Haematol 74:407-17. 2005

Collaborators

Detail Information

Publications6

  1. ncbi The role of soluble CD23 in distinguishing stable and progressive forms of B-chronic lymphocytic leukemia
    Josef D Schwarzmeier
    Department of Hematology, Clinic of Internal Medicine I, University of Vienna, Austria
    Leuk Lymphoma 43:549-54. 2002
    ..It appears that B-CLL patients can be divided into different risk categories according to initial determinations of sCD23 and that sCD23-DT is an additional important parameter in predicting disease progression...
  2. doi NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells
    Rainer Hubmann
    Clinic of Internal Medicine I, Department of Haematology and Haemostaseology, Medical University of Vienna, Waehringer Guertel 18 20, Vienna, Austria
    Br J Haematol 148:868-78. 2010
    ..These data suggest that deregulation of NOTCH2 signalling is critically involved in maintaining the malignant phenotype of CLL lymphocytes and point to a link between PKC-delta and NOTCH2 signalling in the leukemic cells...
  3. pmc TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia
    Medhat Shehata
    Department of Hematology, Clinic of Internal Medicine I, Vienna, Austria
    J Clin Invest 113:676-85. 2004
    ..These results show, for the first time to our knowledge, that TGF-beta1 is highly expressed in HCs and is directly involved in the pathogenesis of BM reticulin fibrosis in HCL...
  4. ncbi Effect of combined spa-exercise therapy on circulating TGF-beta1 levels in patients with ankylosing spondylitis
    Medhat Shehata
    Department of Hematology, Clinic of Internal Medicine I, University of Vienna, Austria
    Wien Klin Wochenschr 118:266-72. 2006
    ..The aim of this study was to find evidence for a biological response to speleotherapy in patients with AS and to study the involvement of the antiinflammatory cytokine TGF-beta1 in this response...
  5. ncbi Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia
    Rainer Hubmann
    Department of Hematology, Clinic of Internal Medicine I, University of Vienna, Vienna, Austria
    Blood 99:3742-7. 2002
    ..In conclusion, these data suggest that deregulation of Notch2 signaling is involved in the aberrant expression of CD23 in B-CLL...
  6. ncbi In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells
    Markus Duechler
    Ludwig Boltzmann Institute for Cytokine Research, Department of Hematology, Clinic of Internal Medicine I, University of Vienna, Austria
    Eur J Haematol 74:407-17. 2005
    ....